<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li S</submitter><funding>National Natural Science Foundation of China</funding><funding>National Key Research and Development Program of China</funding><pagination>e70099</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12416371</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>15(9)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The efficacy of subcutaneous immunotherapy (SCIT) in allergic rhinitis (AR) patients varies. Component-resolved diagnostics (CRD) may serve as a useful tool to predict therapeutic responses.&lt;h4>Methods&lt;/h4>Forty-three house dust mite (HDM)-sensitized AR patients undergoing SCIT were enrolled. Clinical data and serum samples were collected at baseline (V1), 15 weeks (V2), and 1 year (V3). The levels of specific immunoglobulin E (sIgE) and sIgG4 to nine HDM components were measured, and a predictive model was established. An independent prospective cohort of 23 patients was used for validation.&lt;h4>Results&lt;/h4>The most prevalent sensitizing components were Dermatophagoides pteronyssinus (Der p) 1, Dermatophagoides farinae (Der f) 1, Der p 2, Der f 2, and Der p 23. The respo</pubmed_abstract><journal>Clinical and translational allergy</journal><pubmed_title>Early Changes in House Dust Mite Component Specific Immunoglobulin Levels Predict the One-Year Efficacy of Allergen Immunotherapy in Patients With Allergic Rhinitis.</pubmed_title><pmcid>PMC12416371</pmcid><funding_grant_id>2022YFC2504100</funding_grant_id><funding_grant_id>82371827</funding_grant_id><funding_grant_id>82271139</funding_grant_id><funding_grant_id>82271138</funding_grant_id><funding_grant_id>82000955</funding_grant_id><pubmed_authors>Li H</pubmed_authors><pubmed_authors>Li J</pubmed_authors><pubmed_authors>Li S</pubmed_authors><pubmed_authors>Feng X</pubmed_authors><pubmed_authors>Han M</pubmed_authors><pubmed_authors>Ma Y</pubmed_authors><pubmed_authors>Lou H</pubmed_authors><pubmed_authors>Xiong F</pubmed_authors></additional><is_claimable>false</is_claimable><name>Early Changes in House Dust Mite Component Specific Immunoglobulin Levels Predict the One-Year Efficacy of Allergen Immunotherapy in Patients With Allergic Rhinitis.</name><description>&lt;h4>Background&lt;/h4>The efficacy of subcutaneous immunotherapy (SCIT) in allergic rhinitis (AR) patients varies. Component-resolved diagnostics (CRD) may serve as a useful tool to predict therapeutic responses.&lt;h4>Methods&lt;/h4>Forty-three house dust mite (HDM)-sensitized AR patients undergoing SCIT were enrolled. Clinical data and serum samples were collected at baseline (V1), 15 weeks (V2), and 1 year (V3). The levels of specific immunoglobulin E (sIgE) and sIgG4 to nine HDM components were measured, and a predictive model was established. An independent prospective cohort of 23 patients was used for validation.&lt;h4>Results&lt;/h4>The most prevalent sensitizing components were Dermatophagoides pteronyssinus (Der p) 1, Dermatophagoides farinae (Der f) 1, Der p 2, Der f 2, and Der p 23. The respo</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Sep</publication><modification>2026-06-02T00:59:41.196Z</modification><creation>2026-05-24T03:07:24.562Z</creation></dates><accession>S-EPMC12416371</accession><cross_references><pubmed>40920495</pubmed><doi>10.1002/clt2.70099</doi></cross_references></HashMap>